About Company
Enzene Biosciences Ltd. is a global Contract Development and Manufacturing Organization (CDMO) primarily focused on developing and manufacturing biosimilars, novel biologics, synthetic peptides, and phytopharmaceuticals, with a strong emphasis on bringing affordable medicines to market quickly through innovation and technological expertise; it is a subsidiary of Alkem Laboratories Ltd., based in Pune, India, and offers a comprehensive range of services including R&D, analytics, and GMP manufacturing across various biologic modalities like monoclonal antibodies, recombinant proteins, and more.
Key points about Enzene Biosciences:
-
Focus on Biosimilars:
A major part of their business revolves around developing and manufacturing biosimilar drugs.
-
CDMO Services:
They provide a complete suite of CDMO services including cell line development, drug product formulation, process development, and manufacturing.
-
Proprietary Technology:
EnzeneX™ is their patented continuous bioprocess manufacturing platform which aims to reduce production costs and improve efficiency.
-
Global Reach:
While based in India, Enzene has a growing presence in the US and Europe with plans to expand further.
-
Innovation Driven:
The company prioritizes research and development to create innovative solutions in the biopharmaceutical industry.
What makes Enzene stand out:
- Commitment to affordability: Their mission is to make high-quality biologics accessible to patients worldwide.
- Expertise in complex modalities: They have capabilities to develop and manufacture a wide range of biologic molecules including monoclonal antibodies, recombinant proteins, and fusion proteins.
- Quality focus: Enzene adheres to strict quality standards and GMP regulations.